Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003005879 | SCV003301902 | pathogenic | not provided | 2022-01-27 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with PLS3-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ile289Valfs*33) in the PLS3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PLS3 are known to be pathogenic (PMID: 24088043, 30405713, 33166085). |